Chemoprevention in prostate cancer. - Abstract - Europe PMC Sign in | Create an account
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …

Prostate cancer is the most frequently diagnosed malignancy in American men. It will be
diagnosed in an estimated 180,400 Americans in 2000, causing death in approximately …

With a dramatic increase in the number of prostate cancers detected as a result of prostate-
specific antigen (PSA) screening and the resulting public focus on the disease, a lot of …

In highly developed countries like USA, approximately one out of 6 in the male population
will expect to have prostate cancer in their life time. Chemoprevention is presumably one of …

Chemoprevention is defined as the use of specific agents to suppress or reverse
carcinogenesis and to prevent the development of cancer. 1 Chemoprevention trials are …

Because prostate cancer is the most common nondermatologic tumor in US men, an
increased focus has been placed on the disease. Dramatic advances have been made in …

During the twentieth century, approx 20 yr were added to the life expectancy of men and
women in the United States (65). With this increased life expectancy, neoplastic diseases …

The impact of prostate cancer is substantial, and this fact is often cited as the reason for
aggressive screening for and aggressive treatment of the disease. There are, of course …

In absolute terms, prostate cancer is a public health problem of major and increasing
importance particularly as the population ages. Prostate cancer control comprises a series of …

Because prostate cancer has a long latency and high incidence, it is a good target for
chemoprevention by agents such as retinoids, antiandrogens, antiestrogens, and vitamin D …